Arterial Remodeling Technologies And Terumo Corporation: Promising Pre-Clinical Data On The Next Generation Drug Eluting Bioresorbable Scaffold

PARIS--(BUSINESS WIRE)--Terumo and Arterial Remodeling Technologies (ART) announce that, on May 20, 2015, Dr Renu Virmani, internationally renowned cardiovascular pathologist at CVPath Institute, USA, presented promising pre-clinical data on Terumo’s next generation drug eluting bioresorbable scaffold for the treatment of coronary artery disease.

Help employers find you! Check out all the jobs and post your resume.